NLM Logo

Doxorubicin MeSH Descriptor Data 2025


MeSH Heading
Doxorubicin
Tree Number(s)
D02.455.426.559.847.562.050.200.175
D04.615.562.050.200.175
D09.408.051.059.200.175
Unique ID
D004317
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004317
Scope Note
Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
Entry Term(s)
Adriablastin
Adriablastine
Adriamycin
Adriblastin
Adriblastina
Adriblastine
Adrimedac
DOXO-cell
Doxolem
Doxorubicin Hexal
Doxorubicin Hydrochloride
Doxorubicin NC
Doxorubicina Ferrer Farm
Doxorubicina Funk
Doxorubicina Tedec
Doxorubicine Baxter
Doxotec
Farmiblastina
Myocet
Onkodox
Ribodoxo
Rubex
Urokit Doxo-cell
Pharm Action
Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Numbers
80168379AG
82F2G7BL4E
0
Related Numbers
23214-92-8
25316-40-9
82F2G7BL4E
CAS Type 1 Name
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
NLM Classification #
QV 269
Previous Indexing
Antibiotics, Antineoplastic (1967-1972)
Public MeSH Note
78; see ADRIAMYCIN 1973-77
History Note
78(73)
Date Established
1973/01/01
Date of Entry
1999/01/01
Revision Date
2016/07/05
Doxorubicin Preferred
Doxorubicin Hydrochloride Narrower
Doxolem Narrower
Doxorubicine Baxter Narrower
Doxorubicina Tedec Narrower
Doxorubicina Funk Narrower
Doxorubicina Ferrer Farm Narrower
Doxorubicin NC Narrower
Adrimedac Narrower
Doxorubicin Hexal Narrower
DOXO-cell Narrower
Myocet Narrower
Farmiblastina Narrower
Doxotec Narrower
Ribodoxo Narrower
Onkodox Narrower
Rubex Narrower
Adriamycin Narrower
Adriblastin Narrower
page delivered in 0.146s